Development of [C-11]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status

I. Bahce; E.F. Smit; J.M. Lubberink; A.A.M. van der Veldt; M.M. Yaqub; A.D. Windhorst; R.C. Schuit; E. Thunnissen; D.A.M. Heideman; P.E. Postmus; A.A. Lammertsma; N.H. Hendrikse

doi:https://doi.org/10.1158/1078-0432.CCR-12-0289

Development of [C-11]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status

I. Bahce, E.F. Smit, J.M. Lubberink, A.A.M. van der Veldt, M.M. Yaqub, A.D. Windhorst, R.C. Schuit, E. Thunnissen, D.A.M. Heideman, P.E. Postmus, A.A. Lammertsma, N.H. Hendrikse

Research output: Contribution to journal › Article › Academic › peer-review

108 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	183-193
Journal	Clinical Cancer Research
Volume	19
Issue number	1
DOIs	https://doi.org/10.1158/1078-0432.CCR-12-0289
Publication status	Published - 2013

Access to Document

https://doi.org/10.1158/1078-0432.CCR-12-0289

Cite this

Bahce, I., Smit, E. F., Lubberink, J. M., van der Veldt, A. A. M., Yaqub, M. M., Windhorst, A. D., Schuit, R. C., Thunnissen, E., Heideman, D. A. M., Postmus, P. E., Lammertsma, A. A., & Hendrikse, N. H. (2013). Development of [C-11]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status. Clinical Cancer Research, 19(1), 183-193. https://doi.org/10.1158/1078-0432.CCR-12-0289

@article{96531d7ada314258a10bda8e824753f3,

title = "Development of [C-11]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status",

author = "I. Bahce and E.F. Smit and J.M. Lubberink and {van der Veldt}, A.A.M. and M.M. Yaqub and A.D. Windhorst and R.C. Schuit and E. Thunnissen and D.A.M. Heideman and P.E. Postmus and A.A. Lammertsma and N.H. Hendrikse",

year = "2013",

doi = "https://doi.org/10.1158/1078-0432.CCR-12-0289",

language = "Undefined/Unknown",

volume = "19",

pages = "183--193",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "1",

}

Bahce, I, Smit, EF, Lubberink, JM, van der Veldt, AAM, Yaqub, MM , Windhorst, AD , Schuit, RC, Thunnissen, E, Heideman, DAM, Postmus, PE, Lammertsma, AA & Hendrikse, NH 2013, 'Development of [C-11]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status', Clinical Cancer Research, vol. 19, no. 1, pp. 183-193. https://doi.org/10.1158/1078-0432.CCR-12-0289

TY - JOUR

T1 - Development of [C-11]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status

AU - Bahce, I.

AU - Smit, E.F.

AU - Lubberink, J.M.

AU - van der Veldt, A.A.M.

AU - Yaqub, M.M.

AU - Windhorst, A.D.

AU - Schuit, R.C.

AU - Thunnissen, E.

AU - Heideman, D.A.M.

AU - Postmus, P.E.

AU - Lammertsma, A.A.

AU - Hendrikse, N.H.

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.1158/1078-0432.CCR-12-0289

DO - https://doi.org/10.1158/1078-0432.CCR-12-0289

M3 - Article

C2 - 23136193

SN - 1078-0432

VL - 19

SP - 183

EP - 193

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 1

ER -